Web Results

Gilead | Investors | Earnings

investors.gilead.com/phoenix.zhtml?c=69964&p=irol-earnings

The information in these pages is taken from the press releases that correspond to each fiscal quarter ended and should not be deemed accurate or current ...

Biotech Stock Gilead (GILD) Likely to Beat in Q1 Earnings - April 26 ...

www.zacks.com/stock/news/214810/biotech-stock-gilead-gild-likely-to-beat-in-q1-earnings

Apr 26, 2016 ... Gilead Sciences (GILD), which is set to report first-quarter 2016 results on ... Perhaps time to learn more. ... Gilead's blockbuster hepatitis C virus (HCV) drug Harvoni should ... Here are a couple of other health care stocks that you may want to ... Biotech Stock Roundup: Actelion Soars on Acquisition Talks, ...

The Pros and Cons of Buying Gilead Sciences Stock - The Motley Fool

www.fool.com/investing/2016/09/22/the-pros-and-cons-of-buying-gilead-sciences-stock.aspx

Sep 22, 2016 ... Does Gilead Sciences' falling share price offer an opportunity to buy, or should ... six different drugs that are selling at billion-dollar blockbuster clip or better. ... it was only available briefly in the quarter, Epclusa sales were $61 million. ... 5 Things Gilead Sciences' CEO Just Said That You Need to Kn...

Biotech Stock Roundup: Gilead HIV Drug Approved, Baxalta in ...

www.nasdaq.com/article/biotech-stock-roundup-gilead-hiv-drug-approved-baxalta-in-immuno-oncology-deal-cm587513

Mar 2, 2016 ... The fourth quarter earnings season is winding down, with quite a few ... Gilead, known for its strong presence in the HIV and hepatitis C virus ... HIV treatments to market and to boost sales of its blockbuster HIV franchise. ... With limited treatments being available, there is significant unmet need in this area.

Drug Channels: Why Blockbuster Hepatitis C Drugs Are Squeezing ...

www.drugchannels.net/2015/02/why-blockbuster-hepatitis-c-drugs-are.html

Feb 10, 2015 ... In McKesson's second 2015 fiscal quarter (2014's third calendar ... Consider Gilead Sciences' Sovaldi, the hepatitis C drug approved in December 2013. ... To understand wholesaler pricing models, see Chapter 4 of the ... You may be tempted to view specialty drugs as automatically good for wholesalers.

Biotech Stock Roundup: Biotech Stocks Soar on Election Results ...

finance.yahoo.com/news/biotech-stock-roundup-biotech-stocks-131201850.html

Nov 16, 2016 ... Gilead HBV Drug Gains FDA Approval: Gilead GILD, which is facing ... While both drugs have been touted as having blockbuster potential, ... With third quarter earnings season drawing to a close, watch out for pipeline and regulatory updates. ... Today, you can download 7 Best Stocks for the Next 30 Days.

Genetic Stocks to Watch for Earnings on Nov 1: GILD & More - Nasdaq

www.nasdaq.com/article/genetic-stocks-to-watch-for-earnings-on-nov-1-gild-more-cm700965

Oct 31, 2016 ... Moreover, for the quarter, Gilead has an Earnings ESP of +0.37%. ... In the upcoming quarterly earnings call, investor focus should be on the ... Please check our Earnings ESP Filter that enables you find stocks that are ... Biotech Stock Roundup: Ionis Soars on Spinraza Data, Regeneron's Q3 Results Mixed ...

Biotech Stock Roundup: Gilead Gets FDA Nod for HCV Drug ...

finance.yahoo.com/news/biotech-stock-roundup-gilead-gets-182306522.html

Jun 29, 2016 ... Meanwhile, Gilead continues to expand its blockbuster HCV franchise. ... for the duvelisib program, and will focus on submitting a NDA in the fourth quarter of 2016. .... Ever have one of those situations where you find out your brown- bagging .... Social Security Taxes Will Nick More of Your Earnings in 2017.

Sitemap - April, 2015 - Page 1 - - Fortune

fortune.com/sitemap/2015/04/1/

Apr 30, 2015 ... April, 2015; Gilead CEO: “We are taking suggestions” on companies to buy ... of the Affordable Care Act every business leader needs to know about ... Time Warner Cable adds more subscribers, but earnings slip ... Better than you think. .... Apple's blockbuster quarter: What the analysts are saying - updated ...

More Info

Gilead (GILD) Stock Likely to Beat This Earnings Season - July 21 ...

www.zacks.com

Jul 21, 2016 ... Gilead Sciences (GILD), which is set to report second-quarter 2016 ... In the first quarter of 2016, Gilead's hepatitis C virus (HCV) franchise, consisting of blockbuster ... Here are a couple of other health care stocks that you may want to ... Biotech Stock Roundup: Actelion Remains in M&A Spotlight, ASH Data ...

Gilead reports fourth quarter 2015 earnings - CNBC.com

www.cnbc.com

Feb 2, 2016 ... Gilead earnings: $3.32 per share, vs expected EPS of $3 .... Italy's referendum explained: What you need to know · Designated observes watch ...

Gilead (GILD) Stock Likely to Beat This Earnings Season - NASDAQ ...

www.nasdaq.com

Jul 21, 2016 ... Gilead Sciences Inc. GILD is scheduled to report second-quarter 2016 ... Gilead's hepatitis C virus (HCV) franchise, consisting of blockbuster ... Here are a couple of other health care stocks that you may want to ... Pharma Stock Roundup: Data Presented at ACR, Bristol-Myers Inks ... Find a Credit Card ...